Pharmacovigilance. Pharmacovigilance. - Oxford | John Wiley & Sons Ltd | 2007. - 709 Pages Includes Index

Written by an international team of outstanding editors and contributors, Pharmacovigilance, 2nd Edition is the definitive text on this important subject. The new edition has been completely revised and updated to include the latest theoretical and practical aspects of pharmacovigilance including legal issues, drug regulatory requirements, methods of signal generation, reporting schemes and pharmacovigilance in selected system-organ classes. . The editors and contributors are of excellent standing within the pharmacovigilance community The text provides exemplary coverage of all the relevant issues The definitive book on the subject

978-0-470-01803-3 (alk. paper) 0-470-01803-8 = Pharmacovigilance ADR reports ADRs adverse drug reactions adverse events adverse reactions Agency anaemia analysis assessment associated cardiac cardiovascular case–control celecoxib Centre CIOMS Clin Pharmacol clinical trials cohort database disease dose Drug Saf drug safety drug-induced effects elderly electronic enzyme etal European evaluation example exposure factors FDA gastrointestinal genetic GP GPRD guidelines healthcare hepatic hepatotoxicity hospital identified IMMP incidence increased individual inhibitors interactions International investigation liver marketing authorisation MedDRA medicinal products ment metabolism monitoring nomifensine non-steroidal anti-inflammatory drugs NSAIDs number of reports outcomes patients pediatric PEM phar pharmaceutical Pharmacoepidemiology pharmacovigilance Pirmohamed population post-marketing potential pregnancy prenylamine prescribed prescription programme PSUR public health QT interval records registry regulation regulatory renal response risk management rofecoxib serious SOC specific spontaneous reporting studies surveillance syndrome terodiline therapeutic therapy tion torsade de pointes toxicity treatment UK United Kingdom warfarin Yellow Card Yellow Card Scheme

--Medical / General, Medical / Pharmacology, Self-Help / Safety & Security / General, Drug monitoring, Drugs -- Effets secondaires -- Side effects -- Reporting, Drugs -- Side effects -- Reporting, Pharmacoepidemiology, Pharmacovigilance, Pharmacoépidémiologie.

363.194 63 AND